SCHEMBL6538243

SCHEMBL6538243

COCc1cnc2c(NC(=O)c3ccccc3[N+](=O)[O-])cccc2c1N1CCN(C)C1=O

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.43
MEN1 O00255 4/20 0.43
ALDH1A1 P00352 3/20 0.43
L3MBTL1 Q9Y468 3/20 0.43
KDM4E B2RXH2 2/20 0.43
MAPK1 P28482 1/20 0.43
CYP1A2 P05177 3/20 0.42
ABCG2 Q9UNQ0 3/20 0.42
SIRT6 Q8N6T7 1/20 0.40
PKM P14618 1/20 0.40
CYP3A4 P08684 2/20 0.39
POLB P06746 1/20 0.39
MAPT P10636 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6537998 0.86 PTGES (0.45) MAPK1MAPT
SCHEMBL6537657 0.83 PTGES (0.37) KMT2AMEN1ALDH1A1KDM4EPOLB
SCHEMBL6537546 0.81 KMT2A (0.48) KMT2AMEN1ALDH1A1L3MBTL1KDM4E
SCHEMBL6537358 0.80 KDM4E (0.50) KMT2AMEN1ALDH1A1L3MBTL1KDM4E
Hydrochloric Acid SCHEMBL6537552 0.80 KDM4E (0.43) KMT2AMEN1ALDH1A1L3MBTL1KDM4E
SCHEMBL6538307 0.76 MEN1 (0.48) KMT2AMEN1ALDH1A1L3MBTL1KDM4E
SCHEMBL6537499 0.75 KMT2A (0.35) KMT2AMEN1ALDH1A1KDM4EMAPK1
SCHEMBL6537869 0.74 HTT (0.45) KMT2AMEN1ALDH1A1L3MBTL1KDM4E
SCHEMBL6537953 0.74 PTGES (0.37) KMT2AMEN1KDM4EPOLB
SCHEMBL6537705 0.74 MEN1 (0.37) KMT2AMEN1ALDH1A1POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed
EP-0876345-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-11 EP disclosed
WO-1997014681-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-24 WO disclosed